FindTrial
Sign In

Impact of Salivary product Thymosin beta4,bacterial controlling effect on Pain control in braces therapy.

Evaluation of salivary thymosin Beta-4 levels, antimicrobial efficacy and pain perception following platelet rich plasma (PRP) administration during orthodontic therapy - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083304
Enrollment
52
Registered
2025-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: platelet rich plasma: administration of platelet rich plasma and estimation of elevation of salivary thymosin beta4 levels,antimicrobial efficacy and pain control before and after 2 mon

Sponsors

Dr Ramavathu Swetha mouni
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Platelet rich plasma administration

Exclusion criteria

Exclusion criteria: In the experimental groups, platelet rich plasma is administred. saliva and plaque samples will be collected.

Design outcomes

Primary

MeasureTime frame
salivary thymosin beta 4 levels antimicrobial efficacy painTimepoint: baseline,2months,4months,6months after bonding—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactD ARUNA

SIBAR INSTITUE OF DENTAL SCIENCES

drarunaortho@sids.ac.in9490833100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026